| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 10 | Insulin Analog [EPC] | 1 | 0.0000 |